Neuberger Berman Group »

Perspective Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $52k 15k 3.41

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Perspective Therapeutics

BlackRock
TCG Crossover Management
Commodore Capital
Avidity Partners Management
Millennium Management
Vanguard Capital Management
Affinity Asset Advisors
Citadel Advisors
Spruce Street Capital
Balyasny Asset Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Nantahala Capital Management
Goldman Sachs Group

View all funds holding Perspective Therapeutics